In PDAC, p53 is a well-known tumour suppressor: a loss of its functions is critical in dysregulation of cell cycle checkpoints and apoptosis, resulting in acceleration of PDAC progression and metastatic formation in both mouse models of PDAC as well as in pancreatic cancer patients [12, 37–40]. Here, TP53 is linked to neoplasm.